{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:20:39Z","timestamp":1778894439049,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T00:00:00Z","timestamp":1149724800000},"content-version":"vor","delay-in-days":68,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Pathology"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:p>Deposition of conformationally altered proteins prominently characterizes pathogenesis and pathomorphology of a number of neurodegenerative disorders. 2\u2010(1\u2010{6\u2010[(2\u2010[F\u201018]fluoroethyl) (methyl)amino]\u20102\u2010naphthyl} ethylidene) malononitrile ([F\u201018]FDDNP), a hydrophobic, viscosity\u2010sensitive, solvent\u2010sensitive, fluorescent imaging probe has been used with positron emission tomography to visualize brain pathology in the living brain of Alzheimer disease (AD) patients. Its non\u2010radiofluorinated analog FDDNP was shown to label senile plaques and neurofibrillary tangles (NFTs) in brain tissue sections. This work aimed at evaluating FDDNP labeling of various protein deposits in fixed, paraffin\u2010embedded brain tissue sections of selected neurodegenerative disorders: AD, cerebral amyloid angiopathy (CAA), transmissible spongiform encephalopathies, progressive supranuclear palsy (PSP), Pick disease (PiD), Parkinson disease, dementia with Lewy bodies, multiple system atrophy (MSA). Cerebral hypertensive vascular hyalinosis (HVH) was used as negative control. Significant agreement between amyloid histochemical properties and FDDNP labeling of the deposits was established. FDDNP labeling showed high positive predictive value for birefringence in senile plaques and NFTs in AD, prion plaques and amyloid deposits in CAA. No FDDNP labeled structures were observed in HVH, PSP, PiD or MSA tissue sections. Our findings may be of significant value for the detection of neuropathological aggregates with [F\u201018]FDDNP in some of these disorders in the living brain of human subjects.<\/jats:p>","DOI":"10.1111\/j.1750-3639.2006.00006.x","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T13:37:24Z","timestamp":1149773844000},"page":"124-130","source":"Crossref","is-referenced-by-count":39,"title":["The 2,6\u2010Disubstituted Naphthalene Derivative FDDNP Labeling Reliably Predicts Congo Red Birefringence of Protein Deposits in Brain Sections of Selected Human Neurodegenerative Diseases"],"prefix":"10.1111","volume":"16","author":[{"given":"Lojze M.","family":"Smid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomaz D.","family":"Vovko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Petri\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Kepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge R.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaj","family":"Vidmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Bresjanac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00227820"},{"issue":"189","key":"e_1_2_6_3_2","article-title":"Binding characteristics of radiofluorinated 6\u2010dialkylamino\u20102\u2010naphthylethylidene derivatives as positron emission tomography imaging probes for beta\u2010amyloid plaques in Alzheimer\u2019s disease","volume":"21","author":"Agdeppa ED","year":"2001","journal-title":"J Neurosci"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mibio.2003.09.010"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.3.326"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1523\/JNEUROSCI.23-22-08029.2003","article-title":"Molecular\u2010imaging probe 2\u2010(1\u2010[6\u2010[(2\u2010fluoroethyl)(methyl) amino]\u20102\u2010naphthyl]ethylidene) malononitrile labels prion plaques in vitro","volume":"23","author":"Bresjanac M","year":"2003","journal-title":"J Neurosci"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1995.tb00609.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1999.tb00550.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02073-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2003.12.008"},{"key":"e_1_2_6_11_2","first-page":"190","article-title":"The congo red stain revisited","volume":"19","author":"Elghetany MT","year":"1989","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_6_12_2","first-page":"153","volume-title":"Greenfield\u2019s Neuropathology","author":"Esiri M","year":"1997"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-0618(00)00100-9"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.19.9349"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.10.946"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02800.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.08.065"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja9543356"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2534647100"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00334500"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(96)80089-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64099-0"},{"key":"e_1_2_6_23_2","first-page":"1187","volume-title":"Rubin\u2019s Pathology: Clinicopathologic Foundations of Medicine","author":"Kisilevsky R","year":"2004"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","article-title":"The binding of 2\u2010(4\u2032\u2010methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component","volume":"23","author":"Klunk WE","year":"2003","journal-title":"J Neurosci"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.1.1.30"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.5.1113"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.3.707"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1566-2772(01)00023-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00853-1"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:24:2:247"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(98)00241-8"},{"key":"e_1_2_6_32_2","first-page":"5","article-title":"A review of light, polarization and fluorescence microscopic methods for amyloid","volume":"3","author":"Puchtler H","year":"1985","journal-title":"Appl Pathol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61769-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi000637v"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(02)00196-1"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200201000-00004"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6469"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004800906"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90602-5"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2002.03024.x"}],"container-title":["Brain Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1750-3639.2006.00006.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1750-3639.2006.00006.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:05:56Z","timestamp":1697407556000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-3639.2006.00006.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1111\/j.1750-3639.2006.00006.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1750-3639.2006.00006.x","archive":["Portico"],"relation":{},"ISSN":["1015-6305","1750-3639"],"issn-type":[{"value":"1015-6305","type":"print"},{"value":"1750-3639","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}